Antibody and T-cell responses associated with experimental human malaria infection or vaccination show limited relationships (Q41620472)

5 October 2017

title

Antibody and T-cell responses associated with experimental human malaria infection or vaccination show limited relationships (English)

1 reference

5 October 2017

0 references

8

Adrian V S Hill

1 reference

5 October 2017

David R Cavanagh

7

0 references

Stephen M Todryk

object named as

Stephen M Todryk

9

0 references

Gerd Pluschke

6

object named as

Gerd Pluschke

1 reference

5 October 2017

Karen M Walker

1

1 reference

5 October 2017

Shinji Okitsu

2

1 reference

5 October 2017

David W Porter

3

1 reference

5 October 2017

Christopher Duncan

4

1 reference

5 October 2017

Mario Amacker

5

1 reference

5 October 2017

publication date

1 May 2015

1 reference

5 October 2017

1 reference

5 October 2017

volume

145

1 reference

5 October 2017

issue

1

1 reference

5 October 2017

page(s)

71-81

1 reference

Global malaria mortality between 1980 and 2010: a systematic analysis

5 October 2017

cites work

1 reference

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

21 January 2018

1 reference

How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions?

21 January 2018

1 reference

Lymphokine control of in vivo immunoglobulin isotype selection.

21 January 2018

1 reference

B-T lymphocyte interactions in the generation and survival of memory cells.

21 January 2018

1 reference

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

21 January 2018

1 reference

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector

21 January 2018

1 reference

DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity

21 January 2018

1 reference

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial

21 January 2018

1 reference

Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & children

21 January 2018

1 reference

Contribution of influenza immunity and virosomal-formulated synthetic peptide to cellular immune responses in a phase I subunit malaria vaccine trial

21 January 2018

1 reference

Does malaria suffer from lack of memory?

21 January 2018

1 reference

Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children

21 January 2018

1 reference

Class and subclass selection in parasite-specific antibody responses

21 January 2018

1 reference

Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites

21 January 2018

1 reference

The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum

21 January 2018

1 reference

Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion

21 January 2018

1 reference

Young lives lost as B cells falter: what we are learning about antibody responses in malaria

21 January 2018

1 reference

Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells.

21 January 2018

1 reference

Malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen-specific T cells

21 January 2018

1 reference

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

21 January 2018

1 reference

Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study

21 January 2018

1 reference

Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans

21 January 2018

1 reference

Enhancement of naturally acquired immunity against malaria by drug use.

21 January 2018

1 reference

Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum

21 January 2018

1 reference

Multiple functions of human T cells generated by experimental malaria challenge

21 January 2018

1 reference

Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection

21 January 2018

1 reference

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine

21 January 2018

1 reference

The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming

21 January 2018

1 reference

A malaria vaccine based on the polymorphic block 2 region of MSP-1 that elicits a broad serotype-spanning immune response

21 January 2018

1 reference

Significance of immunity against lung pathogens in untreated Parkinson's disease

21 January 2018

1 reference

Substantially reduced pre-patent parasite multiplication rates are associated with naturally acquired immunity to Plasmodium falciparum

21 January 2018

1 reference

Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria

21 January 2018

1 reference

Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness

21 January 2018

1 reference

High antibody responses against Plasmodium falciparum in immigrants after extended periods of interrupted exposure to malaria

21 January 2018

1 reference

Cytokine and antibody responses to Plasmodium falciparum in naïve individuals during a first malaria episode: effect of age and malaria exposure

21 January 2018

1 reference

Stable T-bet(+)GATA-3(+) Th1/Th2 hybrid cells arise in vivo, can develop directly from naive precursors, and limit immunopathologic inflammation.

21 January 2018

1 reference

The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses

21 January 2018

1 reference

Molecular programming of B cell memory

21 January 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4405325

Short report: IgG1/IgG3 antibody responses to various analogs of recombinant ypfmsp119--a study in immune adults living in areas of Plasmodium falciparum transmission

4 November 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4405325

Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria

4 November 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4405325

Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2

4 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25471322

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25471322

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/IMM.12428

1 reference

5 October 2017

0 references

1 reference